Interim Healthcare vs ACASA Senior Care

ACASA Senior Care wins on budget and timing. Its per-unit revenue of $6.9 million signals franchisees with serious operational spend, and a low $83k–$134k initial investment means owners keep more cash for software that coordinates high-touch home-care scheduling, marketing automation, and back-office compliance. That’s a buyer with deep pockets and immediate pain points you can solve. Interim Healthcare’s larger network can’t match that unit economics bullet—no AUV disclosed, but a far higher startup range ($156k–$239k) suggests tighter marginal capital, and a -3.4% contraction tells you operators are shedding locations, not buying new tools.

On terrain, ACASA’s tiny footprint (8 units) is an advantage, not a weakness. The chain is forming its tech stack now. A vendor that embeds early as an approved supplier controls the standard as the brand rockets at 40% annual unit growth; you’re selling into a greenfield, not fighting incumbents in a shrinking 230-unit base where incumbency and cost-cutting freeze RFP cycles. The tradeoff is clear: you sacrifice today’s volume for an expanding, high-revenue install base that will multiply your deal flow with every new franchise award.

Verdict: ACASA Senior Care’s budget depth and explosive growth make it the superior software-sales bet right now, dwarfing Interim Healthcare’s sheer unit count.